A publisher may welcome an AI search tool but reject model training; a studio may license reference access while protecting performer likeness; an AI supplier may know where data came from without holding the rights needed for every use. The public debate often compresses those decisions into “AI versus copyright”, leaving businesses with no practical route forward. The UK’s 2024 consultation closed, and government published a report and impact assessment in March 2026, but policy analysis does not silently rewrite existing copyright law or a private licence. The first commercial opportunity is a one-catalogue, one-use-case rights-and-provenance review that identifies works, rightsholders, access, intended acts, contracts, evidence and unresolved permissions. This reading shows how a rights, licensing or creative-technology specialist can package that decision and build recurring clearance control without promising ownership, non-infringement, a future legal outcome or licensing revenue.
What is the current UK copyright starting point for AI projects?
Current copyright law protects qualifying works and controls specified restricted acts, subject to licences and statutory exceptions. Whether an AI activity requires permission depends on the works, acts, access, purpose, contracts and jurisdiction; a government consultation or impact assessment does not itself grant a general training right.
The Copyright, Designs and Patents Act 1988 remains the legal foundation. The project team should avoid announcing a universal answer before mapping the actual copies, analyses, outputs and communications involved. Legal counsel decides contested interpretation; the operational specialist builds the evidence needed for that advice.
- 1Work, recording, image, text or dataset
- 2Rightsholder and contractual authority
- 3Source and lawful access path
- 4Étape 4
- 5Output, distribution and retained evidence
Why must training, retrieval and assisted creation be separated?
Training a general model, indexing a licensed archive, retrieving passages for a user and helping an employee draft new material create different technical acts and commercial purposes. Treating them as one “AI use” hides which works are touched, what is stored and which permission or exception is being relied upon.
Start with a use-case diagram: input source, ingestion, retention, model or service, prompt, retrieved context, output, user and onward distribution. A hosted supplier may perform some acts while the creative business performs others. Contracts and technical controls must match that allocation.
- id6a76376911a53f0001fa3327
- chartTypebar
- isModelledDatatrue
- rawtype: ai-use-rights-matrix title: Test each AI act against the relevant evidence columns: - Ingest or copy - Analyse or train - Retrieve or display - Generate or transform - Publish or license rows: - Work and rightsholder - Permission or legal basis - Contract and territory - Technical control - Provenance record
- rowsWork and rightsholder · Permission or legal basis · Contract and territory · Technical control · Provenance record
- columnsIngest or copy · Analyse or train · Retrieve or display · Generate or transform · Publish or license
What should the first paid AI-rights purchase deliver?
The first purchase should be a fixed-scope review of one catalogue and one proposed AI use. It should end with a rights map, provenance gaps, contract constraints, permitted and prohibited acts, questions for counsel, technical controls and a decision to proceed, license, redesign, negotiate or stop.
The scope might be one image archive used for semantic search, one voice catalogue considered for synthetic production or one text collection offered for model access. A narrow decision creates value faster than an enterprise “AI policy” that cannot answer what anyone may do tomorrow.
Which provenance evidence should exist before negotiation?
A defensible provenance record identifies the work or dataset, contributor and rightsholder, source, acquisition date, licence or assignment, territory, term, permitted uses, restrictions, model or supplier, transformations and output destination. Missing fields should be visible rather than replaced with an assumption of ownership.
| Evidence | Commercial decision | Warning sign |
|---|---|---|
| Catalogue identity and versions | What is in scope? | Duplicate or orphaned records |
| Rights and contributor chain | Who may authorise use? | Rights split by format or territory |
| Source and access record | How was material obtained? | Provenance cannot be reproduced |
| Licence and restriction | Which acts are permitted? | “AI” not addressed or term expired |
| Technical and output log | What happened in practice? | No link between input and use |
When does licensing become more practical than prohibition?
Licensing becomes practical when the parties can define valuable content, permitted acts, excluded uses, access controls, attribution or reporting, payment logic, audit evidence, term and exit. A licence cannot price uncertainty that neither party is willing to describe or technically control.
Not every catalogue should be licensed for model training. Retrieval, evaluation, internal analysis or limited production tools may offer narrower starting points. The specialist can structure options; the rightsholder chooses the risk and value position with legal advice.
What should an AI supplier prove before receiving creative material?
The supplier should explain what material it receives, where it is processed, whether it is retained or used for training, which subprocessors participate, how access and deletion work, what output evidence exists and how contract restrictions are enforced. Marketing assurances are not a substitute for a usable data-flow record.
Supplier evidence should be proportionate to the use. A low-risk internal tool and a model-development partnership require different diligence. Where technical facts are unavailable, the decision may be redesign or a controlled pilot rather than an assumed permission.
- Public tool with no confidential input
- Licensed SaaS with restricted retention
- Retrieval over controlled catalogue
- Fine-tuning or model adaptation
- General training or onward model access
How can provenance support revenue instead of becoming paperwork?
Provenance can shorten clearance, segment licensable catalogues, support differentiated terms, answer buyer diligence and reduce the cost of proving what a rightsholder controls. Its value comes from enabling faster decisions and credible offers, not from collecting metadata that no commercial workflow uses.
Prioritise catalogue segments with identifiable owners, clean versions and demand. Use provenance status as a portfolio filter: ready to license, ready after named fixes, restricted, disputed or unsuitable. This creates a commercial pipeline without pretending every asset has the same value.
- Ready for defined use
- Ready after evidence repair
- Negotiation required
- Restricted or disputed
- No current commercial fit
What recurring service follows the first rights review?
A defensible recurring service maintains provenance, reviews new AI uses and suppliers, controls permissions, records licences, samples outputs and reopens decisions when technology, contracts or policy change. It earns renewal by keeping creative use authorised and commercially legible as the catalogue evolves.
The cadence can follow releases, acquisitions, new suppliers and licensing negotiations rather than a generic monthly report. The service should show open permissions, expiring terms, unresolved contributors and uses operating outside the approved design.
- 1Register work and rights
- 2Define proposed AI act
- 3Clear, license or redesign
- 4Control supplier and output
- 5Monitor change and refresh evidence
Which buying events create a credible creative-rights market?
A catalogue digitisation, AI supplier procurement, licensing enquiry, archive acquisition, synthetic-content initiative, contributor challenge or policy change can create a real buying event. Outreach should offer a bounded rights decision, not claim that the prospect’s current AI use is unlawful.
Publishers, labels, studios, agencies, archives, image libraries and AI suppliers form a large but fragmented market. Partnerships with legal, technology and rights-management specialists can reduce trust friction. Selected outbound works when it references an observable catalogue or product event rather than generic AI anxiety.
When is an AI-copyright acquisition offer ready to launch?
Launch when the specialist can define catalogue and use-case scope, protect confidential rights data, distinguish operational mapping from legal advice and deliver a decision without predicting future legislation. The partner must provide rightsholder, contract, technical and commercial access.
The 1988 Act, Intellectual Property Office consultation and the government’s March 2026 report bound public claims. Proposed models and impact assessments remain policy evidence unless and until law changes. Do not publish invented licensing values, infringement rates or claims that provenance guarantees ownership.
Could GetFishNet build a tailored acquisition route for your rights expertise?
GetFishNet can test whether your creative-rights expertise, catalogue access, first review and delivery capacity form a credible acquisition opportunity. The free eligibility test examines current acquisition pain points and development synergies without promising licences, clients, revenue or legal outcomes.
If one buyer has an expensive permission uncertainty and your method can resolve it, we can design a tailored multichannel route around that decision and test market response before expanding.
The eligibility report dates and quantifies it, then tests whether it deserves action.
Reading the diagram. A disease contact only progresses after proof of origin, qualification of the relationship and control of the product concerned.
Text alternative. Telephone, prescriber or incoming request follow different proofs; missing consent causes documented exit.
How can the testing cycle reach a stable operating rhythm?
Relative benchmarks: D00 sets the rules of origin and termination of contact, D14 closes the preparation, W03 to W06 tests the scripts, consents, relationships of more than thirty-six months and ceilings per product, W07 to W08 arbitrator, then M03 stabilizes documented paths. Variances are recorded before any budget extension.
Gantt chart for the testing cycle — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. The foundation secures the right to contact; exploration then measures the quality of requests before any channel stabilization.
Textual alternative. D00 sets consent, D14 audits scripts, W03–W06 tests provenance, W07–W08 cuts discrepancies, M03 maintains compliance.
What financial potential does the model make visible?
Model: 132 qualified conversations, 44 reviews and 26 new customers. Weighted average: 1 527 CHF; monthly total: 39 700 CHF. The projection concerns acquisitions agreed and allocated, without using the ceilings as margin or portfolio value. No national denominator is applied.
Breakdown of acquisitions — NON-EXHAUSTIVE DEMONSTRATION
The chart counts customers, not percentage points.
Reading the diagram. 26 acquisitions represent subscriptions preceded by a controlled origin and relationship; the size of a share does not prejudge either the documentary quality or the maintained value.
Text alternative. The circle distributes customers obtained after verifiable consent, never people simply called. Total: 26 customers, reread with the value specific to each channel.
How do customers, average monthly revenue, and recurring revenue correlate by channel?
| Channel explored | Customers | Average monthly revenue per customer | Monthly Recurring Channel Revenue |
|---|---|---|---|
| Natural and paid referencing | 4 | 1 300 CHF | 5 200 CHF |
| Telephone outreach | 3 | 1 600 CHF | 4 800 CHF |
| Voicemails | 2 | 900 CHF | 1 800 CHF |
| Email Campaigns | 4 | 1 200 CHF | 4 800 CHF |
| Social networks | 3 | 1 400 CHF | 4 200 CHF |
| Partners and prescribers | 3 | 2 000 CHF | 6 000 CHF |
| Events and webinars | 2 | 1 700 CHF | 3 400 CHF |
| Advertising retargeting | 1 | 1 100 CHF | 1 100 CHF |
| Strategic accounts and outbound outreach | 2 | 2 300 CHF | 4 600 CHF |
| Content and press relations | 2 | 1 900 CHF | 3 800 CHF |
| Total / weighted average | 26 | 1 527 CHF | 39 700 CHF |
The value is read again with the product, the applicable ceiling and the cost of controlling the provenance. The product customers × average income totals 39 700 CHF without promising performance.
Monthly recurring revenue by channel — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. Compliant disease contacts, their converted volumes and the corresponding monthly income recompose 39 700 CHF without a value outside the table.
Alternative text. Each height associates an authorized channel, actual assigned customers, and the value specific to their product. Their addition exactly equals monthly 39 700 CHF.
How should acquisition cost be assessed before recurring revenue is scaled?
Arbitration adds proof of consent, script control, relationship data, call supervision and refusal handling and reports the charge to assigned customers. It compares legal origin, product concerned, ceiling, full cost, expected termination and service capacity then reduces any channel that weakens the proof.
Funnel to Retained Monthly Recurring Revenue — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. disease contacts whose origin is demonstrated produce raw 39 700 CHF, then 34 142 CHF after maintaining at 86 %.
Text alternative. 132 conversations become 44 journals and 26 clients for disease contacts whose provenance is demonstrated. 39 700 CHF weighted to 86 % gives 34 142 CHF.
Financial limit. The 70 francs and the sixteen bonuses limit the remuneration; they give neither margin, nor number of contracts, nor maintenance. The 34 142 CHF remains a hypothesis, without reference value or forecast.
Which sources and related readings deepen this analysis?
Text references: Federal Office of Public Health, decision and rules applicable to intermediaries; monitoring activity report. The federal office describes ceilings and outreach, while consent and history remain evidence specific to the file. The addresses remain in the internal source register. Each topic retains a clear documentary boundary.
The ISA 2024 processes the status. The ICA 2022 processes the contract trace. The nLPD 2023 shows another prequalification of the contact and data.
CORRELATED READINGS — DYNAMIC MODULE
The thematic map will link rules 2024 of health insurance intermediaries to ISA for status, ICA for contract and nLPD for legality of contact data. The links remain governed without implying equivalence.
- See the insurance & brokerage market
- Explore all market readings
- Test the eligibility of your own window
The September deadline has passed; each origin of contact must always be able to be explained The report isolates the proof and the next action without reopening the 2024 rules of health insurance intermediaries.
The topic is broken down into entities, attributes, evidence, channels, costs and decision points. Institutions are cited in the text; no external resource interrupts the reading path.